116 related articles for article (PubMed ID: 10510365)
1. Systemic expression of rat soluble retinal antigen induces resistance to experimental autoimmune uveoretinitis.
McPherson SW; Roberts JP; Gregerson DS
J Immunol; 1999 Oct; 163(8):4269-76. PubMed ID: 10510365
[TBL] [Abstract][Full Text] [Related]
2. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols.
Gregerson DS; Obritsch WF; Donoso LA
J Immunol; 1993 Nov; 151(10):5751-61. PubMed ID: 7693817
[TBL] [Abstract][Full Text] [Related]
3. Thymic expression of autoantigens correlates with resistance to autoimmune disease.
Egwuagu CE; Charukamnoetkanok P; Gery I
J Immunol; 1997 Oct; 159(7):3109-12. PubMed ID: 9317106
[TBL] [Abstract][Full Text] [Related]
4. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
[TBL] [Abstract][Full Text] [Related]
5. Retinal expression of a neo-self antigen, beta-galactosidase, is not tolerogenic and creates a target for autoimmune uveoretinitis.
Gregerson DS; Torseth JW; McPherson SW; Roberts JP; Shinohara T; Zack DJ
J Immunol; 1999 Jul; 163(2):1073-80. PubMed ID: 10395707
[TBL] [Abstract][Full Text] [Related]
6. Peripheral expression of rod photoreceptor arrestin induces an epitope-specific, protective response against experimental autoimmune uveoretinitis.
McPherson SW; Roberts JP; Gregerson DS
Curr Eye Res; 2005 Jun; 30(6):491-502. PubMed ID: 16020282
[TBL] [Abstract][Full Text] [Related]
7. In vitro unresponsiveness to autologous sequences of the immunopathogenic autoantigen, S-antigen.
Fling SP; Donoso LA; Gregerson DS
J Immunol; 1991 Jul; 147(2):483-9. PubMed ID: 1712808
[TBL] [Abstract][Full Text] [Related]
8. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis.
Prendergast RA; Iliff CE; Coskuncan NM; Caspi RR; Sartani G; Tarrant TK; Lutty GA; McLeod DS
Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):754-62. PubMed ID: 9538882
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of experimental autoimmune uveoretinitis in rats by S-antigen-specific monoclonal antibodies.
De Kozak Y; Mirshahi M; Boucheix C; Faure JP
Eur J Immunol; 1985 Nov; 15(11):1107-11. PubMed ID: 3877637
[TBL] [Abstract][Full Text] [Related]
10. [Experimental autoimmune uveitis and retinitis induced by S-antigen immunization].
Misiuk-Hojło M; Ruiz-Moreno J; Thillaye B; de Kozak Y
Klin Oczna; 1993; 95(3-4):101-4. PubMed ID: 8377430
[TBL] [Abstract][Full Text] [Related]
11. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response.
Caspi RR; Silver PB; Chan CC; Sun B; Agarwal RK; Wells J; Oddo S; Fujino Y; Najafian F; Wilder RL
J Immunol; 1996 Sep; 157(6):2668-75. PubMed ID: 8805672
[TBL] [Abstract][Full Text] [Related]
12. Oligopeptides of three to five residues derived from uveitopathogenic sites of retinal S-antigen induce experimental autoimmune uveitis (EAU) in Lewis rats.
Sunil S; Eto K; Singh VK; Shinohara T
Cell Immunol; 1993 Apr; 148(1):198-207. PubMed ID: 8495487
[TBL] [Abstract][Full Text] [Related]
13. Suppression of experimental autoimmune uveitis in Lewis rats by oral administration of recombinant Escherichia coli expressing retinal S-antigen.
Singh VK; Anand R; Sharma K; Agarwal SS
Cell Immunol; 1996 Sep; 172(2):158-62. PubMed ID: 8964076
[TBL] [Abstract][Full Text] [Related]
14. Immunization with recombinant Escherichia coli expressing retinal S-antigen-induced experimental autoimmune uveitis (EAU) in Lewis rats.
Eto K; Suzuki S; Singh VK; Shinohara T
Cell Immunol; 1993 Mar; 147(1):203-14. PubMed ID: 8462112
[TBL] [Abstract][Full Text] [Related]
15. Rodent models of experimental autoimmune uveitis.
Agarwal RK; Caspi RR
Methods Mol Med; 2004; 102():395-419. PubMed ID: 15286397
[TBL] [Abstract][Full Text] [Related]
16. Participation of non-major histocompatibility antigen complex gene in experimental autoimmune uveitis.
Yoshikawa K; Hirose S; Sasamoto Y; Kotake S; Matsuda H
Jpn J Ophthalmol; 1995; 39(4):347-52. PubMed ID: 8926641
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate.
Kitamei H; Iwabuchi K; Namba K; Yoshida K; Yanagawa Y; Kitaichi N; Kitamura M; Ohno S; Onoé K
J Leukoc Biol; 2006 Jun; 79(6):1193-201. PubMed ID: 16574770
[TBL] [Abstract][Full Text] [Related]
18. Ocular injection of retinal S antigen: suppression of autoimmune uveitis.
Mizuno K; Clark AF; Streilein JW
Invest Ophthalmol Vis Sci; 1989 Apr; 30(4):772-4. PubMed ID: 2784789
[TBL] [Abstract][Full Text] [Related]
19. B-cell delivered gene transfer of human S-Ag-Ig fusion protein protects from experimental autoimmune uveitis.
Liang W; Karabekian Z; Mattapallil M; Xu Q; Viley AM; Caspi R; Scott DW
Clin Immunol; 2006 Jan; 118(1):35-41. PubMed ID: 16168712
[TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin.
Kohno H; Sakai T; Saito S; Okano K; Kitahara K
Exp Eye Res; 2007 Mar; 84(3):569-76. PubMed ID: 17208229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
